IP Verse

Multivalent Pcv2 Immunogenic Compositions And Methods Of Producing Them - EP2275132

The patent EP2275132 was granted to Boehringer Ingelheim Animal Health USA on Mar 3, 2021. The application was originally filed on Dec 28, 2006 under application number EP10174464A. The patent is currently recorded with a legal status of "Granted And Under Opposition".

EP2275132

BOEHRINGER INGELHEIM ANIMAL HEALTH USA
Application Number
EP10174464A
Filing Date
Dec 28, 2006
Status
Granted And Under Opposition
Jan 29, 2021
Publication Date
Mar 3, 2021
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions (3)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

CEVA SANTE ANIMALEDec 2, 2021CABINET BECKER ET ASSOCIES -
ELANCONov 22, 2021POTTER CLARKSONADMISSIBLE
LABORATORIOS HIPRAMar 4, 2021GRUNECKER PATENTADMISSIBLE

Patent Citations (31) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
DESCRIPTIONUS20050034797
DESCRIPTIONUS2909462
DESCRIPTIONUS4708871
DESCRIPTIONUS6703023
OPPOSITIONCA2784260
OPPOSITIONEP0784685
OPPOSITIONEP1094070
OPPOSITIONEP1474067
OPPOSITIONEP1926496
OPPOSITIONEP1968630
OPPOSITIONEP2473189
OPPOSITIONGB2282811
OPPOSITIONUS2002146432
OPPOSITIONUS2003170270
OPPOSITIONUS4745051
OPPOSITIONUS6391314
OPPOSITIONUS6703023
OPPOSITIONUS7122192
OPPOSITIONWO0001409
OPPOSITIONWO0116330
OPPOSITIONWO2005009462
OPPOSITIONWO2005011731
OPPOSITIONWO2006072065
OPPOSITIONWO2006099561
OPPOSITIONWO2018115435
OPPOSITIONWO9307898
OPPOSITIONWO9418311
SEARCHUS2004132178
SEARCHUS6391314
SEARCHWO2005009462
SEARCHWO2006072065

Non-Patent Literature (NPL) Citations (77) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference Text
DESCRIPTION- ALTSCHUL, S. ET AL., BLAST Manual, NCVI NLM NIH
DESCRIPTION- ALTSCHUL, S. F. ET AL., J. MOLEC. BIOL., (1990), vol. 215, pages 403 - 410
DESCRIPTION- BERGMANN ET AL., EUR. J. IMMUNOL., (1993), vol. 23, pages 2777 - 2781
DESCRIPTION- BERGMANN ET AL., J. IMMUNOL., (1996), vol. 157, pages 3242 - 3249
DESCRIPTION- CARILLO, H.LIPMAN, D., SIAM J. APPLIED MATH., (1988), vol. 48, page 1073
DESCRIPTION- DEVEREUX, J. ET AL., NUCLEIC ACIDS RESEARCH, (1984), vol. 12, no. 1, page 387
DESCRIPTION- GEYSEN ET AL., MOLEC. IMMUNOL., (1986), vol. 23, pages 709 - 715
DESCRIPTION- GEYSEN ET AL., PROC. NATL. ACAD. SCI. USA, (1984), vol. 81, pages 3998 - 4002
DESCRIPTION- GLENN E. MORRIS,, Epitope Mapping Protocols in Methods in Molecular Biology, HUMANA PRESS, (1996), vol. 66
DESCRIPTION- HUNTER ET AL., The Theory and Practical Application of Adjuvants, JOHNWILEY AND SONS, (1995), pages 51 - 94
DESCRIPTION- JOURNAL OF GENERAL VIROLOGY, (2000), vol. 81, pages 2281 - 2287
DESCRIPTION- MINION ET AL., J. BACTERIOL., (2004), vol. 186, pages 7123 - 33
DESCRIPTION- M. POWELL AND M. NEWMAN,, Vaccine Design, The Subunit and Adjuvant Approach, PLENUM PRESS, (1995), page 147
DESCRIPTION- PHAMEUROPA, (199606), vol. 8, no. 2
DESCRIPTION- SUHRBIER, A., IMMUNOL. AND CELL BIOL., (1997), vol. 75, pages 402 - 408
DESCRIPTION- TODD ET AL., VACCINE, (1997), vol. 15, pages 564 - 570
DESCRIPTION- VASCONCELOS ET AL., J. BACTERIOL., (2005), vol. 187, pages 5568 - 77
EXAMINATION- HUANG Y.L. ET AL, "Porcine circovirus type 2 (PCV2) infection decreases the efficacy of an attenuated classical swine fever virus (CSFV) vaccine", VETERINARY RES., (2011), vol. 42, page 115
EXAMINATION- THACKER E.L. ET AL., "Effect of vaccination on the potentiation of porcine reproductive and respiratory syndrome virus (PRRSV)-induced pneumonia by Mycoplasma hyopneumoniae", VACCINE, (2000), vol. 18, pages 1244 - 1252
EXAMINATION- VIDOR E, "The nature and consequences of intra- and inter-vaccine interference", J. COM. PATH., (2007), vol. 137, pages S62 - S66
EXAMINATION- Williams et al, Eds., Combined vaccines and simultaneous administration: Current issues and perspectives, NY, New York Academy of Science, (1995), vol. 754, page xi-xv, 35-47, ISBN 0-89766-863-4
OPPOSITION- Anonymous /, "Circo/MycoGard® Porcine Circovirus Vaccine, Type 2, Killed Baculovirus Vector, Mycoplasma hyopneumoniae Bacterin", Circo/MycoGard®, (20180101), pages 1 - 2, Circo/MycoGard® , URL: https://www.pharmgate.com/usa/wp-content/uploads/2018/05/CircoMycoGard-US_Product-Profile-1442-0518.pdf, (20230807), XP093071370
OPPOSITION- Anonymous, "Combination Vaccine", National Hog Farmer, (20031215), vol. 48, page 1, XP055802169
OPPOSITION- Anonymous, "Ingelvac (Reg) CircoFLEX (TM)", Boehringer Ingelheim - Technical Bulletin, (20060101), Boehringer Ingelheim - Technical Bulletin, (20201005), XP055736386
OPPOSITION- Anonymous, "Platforms for Protein-Based Vaccines | Encyclopedia MDPI", Encyclopedia MDPI, (20210101), pages 1 - 1, Encyclopedia MDPI, URL: https%3A%2F%2Fencyclopedia.pub%2Fentry%2F12851, (20230807), XP093071364
OPPOSITION- A. P. Schinckel, et al, "Analysis of Pig Growth from Birth to Sixty Days of Age", Swine Research Report. Purdue University, American Registry of Professional Animal Scientists, (20030101), pages 57 - 67, Swine Research Report. Purdue University, URL: http://www.ansc.purdue.edu/swine/swineday/sday03/10.pdf, (20160602), XP055277371
OPPOSITION- A. Urniza, Et Al., "Abstract No: P.07-09 DURATION OF IMMUNITY STUDY IN PIGS VACCINATED WITH AN INACTIVATED/ADJUV ANTED VACCINE 'CHIMERIC PORCINE CIRCOVIRUS TYPE 1/TYPE 2' IN FRONT OF A CHALLENGE WITH PCV2 EUROPEAN STRAIN", Clinical and Vaccine Immunology, American Society for Microbiology, (20060101), vol. 2, ISSN 1556-6811, page 108, XP055446549
OPPOSITION- BOGA JOSE A ET AL, "A single dose immunization with rabbit haemorrhagic disease virus major capsid protein produced in Saccharomyces cerevisiae induces protection", Journal of General Virology, (19970101), vol. 78, no. 9, ISSN 0022-1317, pages 2315 - 2318, XP002450362
OPPOSITION- C Charreyre, A Brun, C Aerberle, L Boeuf, P Brocard And G Chappuis, "Vaccination challenge trials with an inactivated vaccine against PRRS", Proceedings of the 15th IPVS Congress, (19980705), page 1392, XP055525284
OPPOSITION- Eichmeyer Marc A, Roof Michael B, Piontkowski Michael D, Hayes Philip W, Saltzman Ryan, "Efficacy evaluation of a mixed Mycoplasma hyopneumoniae bacterin and a porcine circovirus type 2 vaccine", American Assoc of Swine Vet, (20090101), pages 299 - 300, XP093108199
OPPOSITION- Fan Et Al, "baculovirus insect expression and immunological studies of porcin circovirus type 2 capsid protein", Proc. 2nd Asian Pig Vet. Soc. Congress, (20050101), pages 186 - 188, Proc. 2nd Asian Pig Vet. Soc. Congress, (20160802), XP055292702
OPPOSITION- Hana M. Weingartl, "Porcine circovirus structure and replication a minireview", Agricultura, (20020101), vol. 1, pages 11 - 14, XP055292683
OPPOSITION- Ingelvac® CircoFlex
OPPOSITION- Ladekjaer-Mikkelsen A.-S., Nielsen J, Stadejek T, Storgaard T, Krakowka S, Ellis J, Mcneilly F, Allan G, Botner A, "Reproduction of postweaning multisystemic wasting syndrome (PMWS) in immunostimulated and non-immunostimulated 3-week-old piglets experimentally infected with porcine circovirus type 2 (PCV2)", Veterinary Microbiology, (20020101), vol. 89, pages 97 - 114, XP055812921
OPPOSITION- Lisa Truchan, Rika Jolie, Paul Runnels, David McGavin, "Eighteen Week Duration of Immunity in Pigs Vaccinated at 3 or 8 Weeks of Age with One Dose of a Mycoplasma hyopneumoniae Bacterin", PROCEEDINGS OF THE AMERICAN ASSOCIATION OF SWINE PRACTITIONERS CONFERENCE 2000; INDIANAPOLIS, INDIANA; MARCH 11-14, 2000, (20000311), page 125, XP002734481
OPPOSITION- Marlin Hoogland, Opriessnig, Halbur, "Effects of adjuvants on porcine circovirus type 2-associated lesions", Journal of Swine Health and Production, (20060501), vol. 14, no. 3, pages 133 - 139, XP055031472
OPPOSITION- MENGELING, Journal of Swine Health and Production, (20050500), pages 152 - 156
OPPOSITION- Michael B Roof, Kelly Burkhart and Federico A Zuckerman, "Evaluation of the immune response and efficacy of 1 and 2 dose commercial Mycoplasma hyopneumoniae bacterins", AASV, (20010101), pages 163 - 167, AASV, (20181018), XP055516930
OPPOSITION- Michael Haake, Andreas Palzer, Beate Rist, Christiane Weissenbacher-Lang, Vicky Fachinger, Alex Eggen, Mathias Ritzmann, Matthias Eddicks, "Influence of age on the effectiveness of PCV2 vaccination in piglets with high levels of maternally derived antibodies", Vet. Microbiol., (20130101), vol. 168, pages 1 - 9, XP055502963
OPPOSITION- Michael Haake et al, "Influence of age on the effectiveness of PCV2 vaccination in piglets with high levels of maternally derived antibodies", Vet. Microbiol., (20130101), vol. 168, pages 1 - 9, XP055502963
OPPOSITION- NAWAGITGUL P, ET AL., "Open reading frame 2 of porcine circovirus type 2 encodes a major capsid protein", Journal of General Virology, (20000101), vol. 81, no. 9, ISSN 0022-1317, pages 2281 - 2287, XP002978778
OPPOSITION- Pat Halbur, Opriessnig Tanja, "Porcine Circovirus Associated Disease (PCVAD)… a "Double Bogey"", Carthage Veterinary Service Ltd. 16th Annual Swine Conference, (20060101), pages 1 - 71, Carthage Veterinary Service Ltd. 16th Annual Swine Conference, URL: http://www.prairieswine.com/pdf/36144.pdf, (20160602), XP055277398
OPPOSITION- P.P. Pastoret, J. Blancou, P. Vannier And C. Verschueren, P. Desmettre And S. Martinod, "Research and Development (Chapter 9)", Veterinary Vaccinology, Elsevier , (19970101), pages 175,177 - 178, ISBN 978-0-444-81968-0, XP055277388
OPPOSITION- Reynaud, Et Al., "Safety of a high dose administration of an inactivated adjuvanted PCV2 vaccine in conventional gilts", IPVS, (20040101), page 87, IPVS, URL: https://www.aasv.org/library/swineinfo/Content/IPVS/2004/709.pdf, (20181018), XP055516942
OPPOSITION- R. Kelly Schwalbe, "Boehringer Ingelheim Receives APHIS Approval on new Circovirus Vaccine", Boehringer Ingelheim - Press Release, (20060101), Boehringer Ingelheim - Press Release, (20201005), XP055736384
OPPOSITION- Robert Desrosiers, Et Al., "Preliminary results with Ingelvac® CircoFLEX™ to protect multiple ages of Quebec pigs against PCVAD", American Association of swine Veterinarians, (20070101), pages 143 - 146, American Association of swine Veterinarians, (20180131), XP055446462
OPPOSITION- Salmon, Et Al., "Developmental and Comparative Immunology", Dev. Comp. Immunol., (20090101), vol. 33, pages 384 - 393, XP055516948
OPPOSITION- Salmon, "Immunité chez le foetus et le nouveau-né: modèle porcin", Reprod. Nutr. Developpement, (19840101), vol. 24, pages 197 - 206, XP055516981
OPPOSITION- SOFER, BioPharm International, (20030100), pages 50 - 57, XP009171415
OPPOSITION- THACKER, E.L. ET AL., "Effect of vaccination on the potentiation of porcine reproductive and respiratory syndrome virus (PRRSV)-induced pneumonia by Mycoplasma hyopneumoniae", (20000121), vol. 18, no. 13, pages 1244 - 1252, XP002404958
OPPOSITION- VOLKER GERDTS, LORNE A. BABIUK, SYLVIA VAN DRUNEN LITTEL-VAN DEN HURK& PHILIP J. GRIEBEL, "Fetal immunization by DNA vaccine delivered into the oral cavity", Nat. Med., (20000801), vol. 6, no. 8, pages 929 - 932, XP055516967
OPPOSITION- Volker Gerdts, Marlene Snider, Robert Brownlie, Lorne A. Babiuk and Philip J. Griebel, "Oral DNA Vaccination In Utero Induces Mucosal Immunity and Immune Memory in the Neonate", The Journal of Immunology, Williams & Wilkins Co., US, US , (20020215), vol. 168, no. 4, ISSN 0022-1767, pages 1877 - 1885, XP055516960
OPPOSITION- Weingartl, "Porcine circovirus structure and replication a minireview", Agricultura, (20020101), pages 11 - 14, XP055292683
OPPOSITION- Yang Siyeon, Ahn Yongjun, Oh Taehwan, Cho Hyejean, Park Kee Hwan, Chae Chanhee, "Field evaluation of a sing‐dose bivalent vaccine of porcine circovirus type 2b and Mycoplasma hyopneumoniae", Veterinary Medicine and Science, (20210501), vol. 7, no. 3, doi:10.1002/vms3.420, ISSN 2053-1095, pages 755 - 765, XP093071354
OPPOSITION- ALLAN G M, ET AL., "EXPERIMENTAL INFECTION OF COLOSTRUM DEPRIVED PIGLETS WITH PORCINE CIRCOVIRUS 2 (PCV2) AND PORCINE REPRODUCTIVE AND RESPIRATORY SYNDROME VIRUS (PRRSV) POTENTIATES PCV2 REPLICATION", Archives of Virology, Springer Wien, AT, AT , (20000101), vol. 145, no. 11, doi:10.1007/s007050070031, ISSN 0304-8608, pages 2421 - 2429, XP001020811
OPPOSITION- Nielsen, J. ; Ronsholt, L. ; Sorensen, K.J., "Experimental in utero infection of pig foetuses with porcine parvovirus (PPV)", VETERINARY MICROBIOLOGY, Elsevier BV, NL, NL , (19910601), vol. 28, no. 1, doi:10.1016/0378-1135(91)90095-W, ISSN 0378-1135, pages 1 - 11, XP023915174
OPPOSITION- Witvliet Maarten, Holtslag Hans, Nell Tom, Segers Ruud, Fachinger Vicky, "Efficacy and safety of a combined Porcine Circovirus and Mycoplasma hyopneumoniae vaccine in finishing pigs", Trials in Vaccinology, (20150101), vol. 4, doi:10.1016/j.trivac.2015.04.002, ISSN 1879-4378, pages 43 - 49, XP093108198
OPPOSITION- Alexopoulos, C. Kritas, S.K. Kyriakis, C.S. Tzika, E. Kyriakis, S.C., "Sow performance in an endemically porcine reproductive and respiratory syndrome (PRRS)-infected farm after sow vaccination with an attenuated PRRS vaccine", VETERINARY MICROBIOLOGY, Elsevier BV, NL, NL , (20051220), vol. 111, no. 3-4, doi:10.1016/j.vetmic.2005.10.007, ISSN 0378-1135, pages 151 - 157, XP005180367
OPPOSITION- K.H. Mair, H. Koinig, W. Gerner, A. Höhne, J. Bretthauer, J.J. Kroll, M.B. Roof, A. Saalmüller, K. Stadler, R. Libanova, "Carbopol improves the early cellular immune responses induced by the modified-life vaccine Ingelvac PRRS® MLV", VETERINARY MICROBIOLOGY, Elsevier BV, NL, NL , (20150401), vol. 176, no. 3-4, doi:10.1016/j.vetmic.2015.02.001, ISSN 0378-1135, pages 352 - 357, XP055308822
OPPOSITION- Bachmann, M.F. Zinkernagel, R.M., "The influence of virus structure on antibody responses and virus serotype formation", IMMUNOLOGY TODAY., ELSEVIER PUBLICATIONS, CAMBRIDGE., GB, GB , (19961201), vol. 17, no. 12, doi:10.1016/S0167-5699(96)10066-9, ISSN 0167-5699, pages 553 - 558, XP004071007
OPPOSITION- Liljeqvist, S. Stahl, S., "Production of recombinant subunit vaccines: protein immunogens, live delivery systems and nucleic acid vaccines", Journal of Biotechnology, Elsevier, Amsterdam NL, Amsterdam NL , (19990730), vol. 73, no. 1, doi:10.1016/S0168-1656(99)00107-8, ISSN 0168-1656, pages 1 - 33, XP004180163
OPPOSITION- Moraes, M.P. Mayr, G.A. Mason, P.W. Grubman, M.J., "Early protection against homologous challenge after a single dose of replication-defective human adenovirus type 5 expressing capsid proteins of foot-and-mouth disease virus (FMDV) strain A24", Vaccine, ELSEVIER, AMSTERDAM, NL, AMSTERDAM, NL , (20020222), vol. 20, no. 11-12, doi:10.1016/S0264-410X(01)00483-2, ISSN 0264-410X, pages 1631 - 1639, XP004340386
OPPOSITION- Blanchard, P. et al, "Protection of swine against post-weaning multisystemic wasting syndrome (PMWS) by porcine circovirus type 2 (PCV2) proteins", Vaccine, AMSTERDAM, NL , (20031107), vol. 21, no. 31, doi:10.1016/S0264-410X(03)00503-6, ISSN 0264-410X, pages 4565 - 4575, XP004467337
OPPOSITION- Blanchard, P. Mahe, D. Cariolet, R. Keranflec'h, A. Baudouard, M.A. Cordioli, P. Albina, E. Jestin, A., "Protection of swine against post-weaning multisystemic wasting syndrome (PMWS) by porcine circovirus type 2 (PCV2) proteins", Vaccine, ELSEVIER, AMSTERDAM, NL, AMSTERDAM, NL , (20031107), vol. 21, no. 31, doi:10.1016/S0264-410X(03)00503-6, ISSN 0264-410X, pages 4565 - 4575, XP004467337
OPPOSITION- NOAD R, ROY P, "Virus-like particles as immunogens", Trends in Microbiology, ELSEVIER SCIENCE LTD., KIDLINGTON., GB, GB , (20030901), vol. 11, no. 9, doi:10.1016/S0966-842X(03)00208-7, ISSN 0966-842X, pages 438 - 444, XP003004438
OPPOSITION- Megan C. Niederwerder, Bawa Bhupinder, Serão Nick V. L., Trible Benjamin R., Kerrigan Maureen A., Lunney Joan K., Dekkers Jack C. M., Rowland Raymond R. R., "Vaccination with a Porcine Reproductive and Respiratory Syndrome (PRRS) Modified Live Virus Vaccine Followed by Challenge with PRRS Virus and Porcine Circovirus Type 2 (PCV2) Protects against PRRS but Enhances PCV2 Replication and Pathogenesis Compared to Results for Nonvaccinated Cochallenged", Clinical and Vaccine Immunology, American Society for Microbiology, (20151201), vol. 22, no. 12, doi:10.1128/CVI.00434-15, ISSN 1556-6811, pages 1244 - 1254, XP055706828
OPPOSITION- A. Rovira, M. Balasch, J. Segales, L. Garcia, J. Plana-Duran, C. Rosell, H. Ellerbrok, A. Mankertz, M. Domingo, "Experimental Inoculation of Conventional Pigs with Porcine Reproductive and Respiratory Syndrome Virus and Porcine Circovirus 2", Journal of Virology, THE AMERICAN SOCIETY FOR MICROBIOLOGY, US, US , (20020401), vol. 76, no. 7, doi:10.1128/JVI.76.7.3232-3239.2002, ISSN 0022-538X, pages 3232 - 3239, XP055527104
OPPOSITION- FENAUX M, ET AL., "A CHIMERIC PORCINE CIRCOVIRUS (PCV) WITH THE IMMUNOGENIC CAPSID GENE FOR THE PATHOGENIC PCV TYPE 2 (PCV2) CLONED INTO THE GENOMIC BACKBONE OF THE NONPATHOGENIC PCV1 INDUCES PROTECTIVE IMMUNITY AGAINST PCV2 INFECTION IN PIGS", Journal of Virology, THE AMERICAN SOCIETY FOR MICROBIOLOGY, US, US , (20040601), vol. 78, no. 12, doi:10.1128/JVI.78.12.6297-6303.2004, ISSN 0022-538X, pages 6297 - 6303, XP008039321
OPPOSITION- Dawson A, Thevasagayam S J, Sherington J, Harvey R E, Peters A R, "STUDIES OF THE FIELD EFFICACY AND SAFETY OF A SINGLE-DOSE MYCOPLASMA HYOPNEUMONIAE VACCINE FOR PIGS", VETERINARY RECORD, BRITISH VETERINARY ASSOCIATION, LONDON, GB, GB , (20021102), vol. 151, no. 18, doi:10.1136/vr.151.18.535, ISSN 0042-4900, pages 535 - 538, XP008048796
OPPOSITION- S. Krakowka, J. A. Ellis, F. Mcneilly, S. Ringler, D. M. Rings, G. Allan, "Activation of the Immune System is the Pivotal Event in the Production of Wasting Disease in Pigs Infected with Porcine Circovirus-2 (PCV-2)", VETERINARY PATHOLOGY., AMERICAN COLLEGE OF VETERINARY PATHOLOGISTS, US, US , (20010101), vol. 38, no. 1, doi:10.1354/vp.38-1-31, ISSN 0300-9858, pages 31 - 42, XP055277395
OPPOSITION- Boisgérault F; Moron G; Leclerc C, "Virus-like particles: a new family of delivery systems", EXPERT REVIEW OF VACCINES, FUTURE DRUGS, LONDON, GB, GB , (20020101), vol. 1, no. 1, doi:10.1586/14760584.1.1.101, ISSN 1476-0584, pages 101 - 109, XP008099122
OPPOSITION- Dong-Kun Yang, Et Al, "Immunogenicity of baculovirus expressed recombinant proteins of Japanese encephalitis virus in mice", J Vet Sci, (20050101), vol. 6, no. 2, doi:10.4142/jvs.2005.6.2.125, pages 125 - 133, XP055670219
SEARCH[ ] - BOEHRINGER INGELHEIM, "Ingelvac CircoFLEX-MycoFLEX Combo pack receives APHIS approval.", PRESS RELEASE, 12 AUGUST 2008, URL: http://flexcombo.com/documents/CircoFLEX-MycoFLEX-APHIS-Approval.pdf [ ] * the whole document *
SEARCH[ ] - BOEHRINGER INGELHEIM, "Ingelvac MycoFLEX", MATERIAL SAFETY DATA SHEET (14-08-2008), URL: http://www.bimsds.us/msds/Ingelvac_MycoFLEX_msds.pdf [ ] * the whole document *
SEARCH- BOEHRINGER INGELHEIM VETMEDICA, "Data from studies consistent with maintaining safety and efficacy of Ingelvac CircoFLEX and Ingelvac MycoFLEX vaccines when mixed toghether and administered concurrently in pigs.", TECHNICAL BULLETIN, FEBRUARY 2008, URL: http://www.bi-vetmedica.com/swine-research/MycoFLEX-Mycoplasma-immunity_TB2.pdf, XP002503389 [T] * the whole document *
SEARCH- BLANCHARD P ET AL, "Protection of swine against post-weaning multisystemic wasting syndrome (PMWS) by porcine circovirus type 2 (PCV2) proteins", VACCINE, BUTTERWORTH SCIENTIFIC. GUILDFORD, GB, (20031107), vol. 21, no. 31, ISSN 0264-410X, pages 4565 - 4575, XP004467337 [Y] 1-14 * the whole document *
SEARCH- BLANCHARD PH ET AL, "An ORF2 protein-based ELISA for porcine circovirus type 2 antibodies in post-weaning multisystemic wasting syndrome", VETERINARY MICROBIOLOGY,, (20030717), vol. 94, no. 3, pages 183 - 194, XP002502413 [A] 1,6 * the whole document *

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents